Atlas Trials

STA-4783/Paclitaxel or Paclitaxel Alone in Melanoma

Clinical trial NCT00084214 · COMPLETED

Trial details

NCT number
NCT00084214
Sponsor
Synta Pharmaceuticals Corp.
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Melanoma
Start date
2004-05-01
Enrollment
103

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.